You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 411 Novel intratumoral agent, INT230–6 induces cancer cell death, increases tumor infiltrates and results in durable benefit alone or in combination with pembrolizumab in refractory patients

Article Text

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
411 Novel intratumoral agent, INT230–6 induces cancer cell death, increases tumor infiltrates and results in durable benefit alone or in combination with pembrolizumab in refractory patients

https://doi.org/10.1136/jitc-2020-SITC2020.0411

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.